AI
Wednesday, October 14, 2009 8:17:08 AM
BMTI Biomimetic Therapeutics tgt raised to $24 at Canaccord Adams following positive top-line data for Augment (12.69 ) -Update-
Canaccord Adams is raising their BMTI tgt to $24 from $19.25 following the co's announcement of positive top-line data from its Augment Bone Graft North American pivotal trial. The firm notes that the results of the trial were extremely positive, as they met the primary endpoint of non-inferiority to autograft on a modified intent-to-treat basis per study protocol. The firm believes that the results of the trial present a very convincing argument for Augment to receive FDA approval. In regards to the intent-to-treat (ITT) population not meeting its primary endpoint, the firm believes that it is irrelevant to the likelihood of FDA approval given the clear study protocol and precedent from previous medical devices, specifically INFUSE.
==============================================
Wonder how this got misinterpreted and sold off initially last night, leading to more selling, then some studying, etc. A few folks are clearly looking stupid right now... 9's last night to 14's this morning....
Canaccord Adams is raising their BMTI tgt to $24 from $19.25 following the co's announcement of positive top-line data from its Augment Bone Graft North American pivotal trial. The firm notes that the results of the trial were extremely positive, as they met the primary endpoint of non-inferiority to autograft on a modified intent-to-treat basis per study protocol. The firm believes that the results of the trial present a very convincing argument for Augment to receive FDA approval. In regards to the intent-to-treat (ITT) population not meeting its primary endpoint, the firm believes that it is irrelevant to the likelihood of FDA approval given the clear study protocol and precedent from previous medical devices, specifically INFUSE.
==============================================
Wonder how this got misinterpreted and sold off initially last night, leading to more selling, then some studying, etc. A few folks are clearly looking stupid right now... 9's last night to 14's this morning....
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
